BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3873787)

  • 1. [Surface marker studies on the activated peripheral blood lymphocytes of Vogt-Koyanagi-Harada's disease].
    Okubo K; Kurimoto S; Okubo K; Yokoyama MM
    Nippon Ganka Gakkai Zasshi; 1985 Feb; 89(2):358-63. PubMed ID: 3873787
    [No Abstract]   [Full Text] [Related]  

  • 2. [Surface marker studies on the peripheral blood lymphocytes of Vogt-Koyanagi-Harada's disease].
    Okubo K; Kurimoto S; Okubo K; Yokoyama M; Matsumoto K; Iwasaki T
    Nippon Ganka Gakkai Zasshi; 1983; 87(11):1250-6. PubMed ID: 6670651
    [No Abstract]   [Full Text] [Related]  

  • 3. [Identification of antibody-producing cells in peripheral lymphocytes of Vogt-Koyanagi-Harada's syndrome with immunocyte adherence (rosette-formation) technique (author's transl)].
    Yuasa T; Matsumoto K; Hoki T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1975 Oct; 79(10):1389-92. PubMed ID: 1239165
    [No Abstract]   [Full Text] [Related]  

  • 4. [Involvement of Ia-positive accessory cells for activation of cytotoxic T lymphocyte specific for melanocyte-associated antigens in patients with Vogt-Koyanagi-Harada disease].
    Maezawa N; Tsukahara S
    Nippon Ganka Gakkai Zasshi; 1985 Mar; 89(3):440-6. PubMed ID: 3874531
    [No Abstract]   [Full Text] [Related]  

  • 5. [Existence of cytotoxic T lymphocytes specific for human melanoma cells in Vogt-Koyanagi-Harada disease (author's transl)].
    Maezawa N
    Nippon Ganka Gakkai Zasshi; 1981 Sep; 85(9):1406-11. PubMed ID: 6976680
    [No Abstract]   [Full Text] [Related]  

  • 6. [Investigation of interferon system in Vogt-Koyanagi-Harada disease].
    Ohno S; Kotake S; Fjuii N; Minagawa T
    Nippon Ganka Gakkai Zasshi; 1982; 86(10):1574-80. PubMed ID: 6187194
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological studies on Behçet's and Harada's diseases. I. Cell-mediated immunity in Behçet's and Harada's diseases. II. HL-A antigens associated with Behçet's disease.
    Sugiura S; Sanefuji M; Ohno S
    Mod Probl Ophthalmol; 1976; 16():267-78. PubMed ID: 1250232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lymphocyte transformation test and migration inhibition test of macrophages in Vogt-Koyanagi-Hirada's syndrome (author's transl)].
    Yuasa T; Murai Y; Hoki T; Mimura Y
    Nippon Ganka Gakkai Zasshi; 1973 Oct; 77(10):1652-7. PubMed ID: 4799026
    [No Abstract]   [Full Text] [Related]  

  • 9. [Surface marker studies of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada diseases].
    Okubo K; Kurimoto S; Okubo K; Yokoyama MM
    Nippon Ganka Gakkai Zasshi; 1985 Jun; 89(6):726-32. PubMed ID: 3877406
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte transformation test in sympathetic ophthalmitis and the Vogt-Koyanagi-Harada syndrome.
    Hammer H
    Br J Ophthalmol; 1971 Dec; 55(12):850-2. PubMed ID: 5168516
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antibody-dependent cell-mediated cytotoxicity (ADCC) against melanocyte antigens in Vogt-Koyanagi-Harada disease (author's transl)].
    Tagawa Y; Sugiura S
    Nippon Ganka Gakkai Zasshi; 1977 Aug; 81(8):1101-4. PubMed ID: 930771
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter: HLA and Vogt-Koyanagi-Harada syndrome.
    Tagawa Y; Sugiura S; Yakura H; Wakisaka A; Aizawa M
    N Engl J Med; 1976 Jul; 295(3):173. PubMed ID: 1272341
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-D antigen of Japanese origin (LD-Wa) and its association with Vogt-Koyanagi-Harada syndrome.
    Yakura H; Wakisaka A; Aizawa M; Itakura K; Tagawa Y
    Tissue Antigens; 1976 Jul; 8(1):35-42. PubMed ID: 60795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymus-derived lymphocytes in the Vogt-Koyanagi-Harada syndrome.
    Char DH; Brunn J; West W
    Invest Ophthalmol Vis Sci; 1977 Feb; 16(2):179-81. PubMed ID: 299856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case report of Vogt-Koyanagi-Harada's syndrome studied with electron microscope].
    Mimura M; Ikui H
    Nihon Ganka Kiyo; 1970 Sep; 21(9):617-31. PubMed ID: 5529819
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological aspects of Behçet's and Vogt-Koyanagi-Harada's diseases.
    Ohno S
    Trans Ophthalmol Soc U K (1962); 1981 Sep; 101 (Pt 3)(3):335-41. PubMed ID: 6820735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement of Ia-positive nylon wool adherent cells for activation of cytotoxic T-lymphocytes specific to melanocyte-associated antigens in patients with Vogt-Koyanage-Harada's disease.
    Maezawa N; Yano A
    Jpn J Ophthalmol; 1988; 32(3):348-57. PubMed ID: 3265967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cell-mediated immunity in uveitis. 2. Leukocyte migration inhibition test in Harada's disease (author's transl)].
    Sanefuji M
    Nippon Ganka Gakkai Zasshi; 1974 Jun; 78(6):306-10. PubMed ID: 4471763
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some observations on uveitis in Japan, with special reference to Vogt-Koyanagi-Harada and Behçet diseases (author's transl)].
    Sugiura S
    Nippon Ganka Gakkai Zasshi; 1976 Nov; 80(11):1285-326. PubMed ID: 1034425
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lymphocyte subsets in peripheral blood and cerebrospinal fluid in Vogt-Koyanagi-Harada disease].
    Kuwasaki N; Shoji H; Kaji M; Matsumoto K; Yokoyama M
    Rinsho Shinkeigaku; 1985 Aug; 25(8):956-9. PubMed ID: 4064437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.